AU2772389A – Inhibitory agent of hepatic fibrosis
– Google Patents
AU2772389A – Inhibitory agent of hepatic fibrosis
– Google Patents
Inhibitory agent of hepatic fibrosis
Info
Publication number
AU2772389A
AU2772389A
AU27723/89A
AU2772389A
AU2772389A
AU 2772389 A
AU2772389 A
AU 2772389A
AU 27723/89 A
AU27723/89 A
AU 27723/89A
AU 2772389 A
AU2772389 A
AU 2772389A
AU 2772389 A
AU2772389 A
AU 2772389A
Authority
AU
Australia
Prior art keywords
inhibitory agent
hepatic fibrosis
hepatic
fibrosis
inhibitory
Prior art date
1988-01-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU27723/89A
Other versions
AU614569B2
(en
Inventor
Munehiro Tomikawa
Junichiro Wakasugi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1988-01-06
Filing date
1989-01-04
Publication date
1989-07-13
1989-01-04
Application filed by Daiichi Pharmaceutical Co Ltd
filed
Critical
Daiichi Pharmaceutical Co Ltd
1989-07-13
Publication of AU2772389A
publication
Critical
patent/AU2772389A/en
1991-09-05
Application granted
granted
Critical
1991-09-05
Publication of AU614569B2
publication
Critical
patent/AU614569B2/en
1991-11-28
Assigned to DAIICHI PHARMACEUTICAL CO., LTD.
reassignment
DAIICHI PHARMACEUTICAL CO., LTD.
Amend patent request/document other than specification (104)
Assignors: DAIICHI SEIYAKU CO. LTD.
2009-01-04
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/16—Amides, e.g. hydroxamic acids
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
A61K31/19—Carboxylic acids, e.g. valproic acid
A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
AU27723/89A
1988-01-06
1989-01-04
Inhibitory agent of hepatic fibrosis
Ceased
AU614569B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
JP106788
1988-01-06
JP63-1067
1988-01-06
Publications (2)
Publication Number
Publication Date
AU2772389A
true
AU2772389A
(en)
1989-07-13
AU614569B2
AU614569B2
(en)
1991-09-05
Family
ID=11491185
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU27723/89A
Ceased
AU614569B2
(en)
1988-01-06
1989-01-04
Inhibitory agent of hepatic fibrosis
Country Status (8)
Country
Link
US
(1)
US4937266A
(en)
EP
(1)
EP0323855B1
(en)
KR
(1)
KR970005324B1
(en)
AU
(1)
AU614569B2
(en)
CA
(1)
CA1318254C
(en)
DE
(1)
DE68914468T2
(en)
ES
(1)
ES2054881T3
(en)
PH
(1)
PH26554A
(en)
Families Citing this family (10)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
JPH02232670A
(en)
*
1989-03-06
1990-09-14
Minolta Camera Co Ltd
Copying machine
US5789426A
(en)
*
1995-01-20
1998-08-04
Cornell Research Foundation, Inc.
Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
US6046219A
(en)
*
1995-01-20
2000-04-04
Cornell Research Foundation, Inc.
Method for the treatment of conditions mediated by collagen formation together with cell proliferation by application of inhibitors of protein hydroxylation
US5965621A
(en)
*
1995-08-17
1999-10-12
Allergan
Methods and compositions for reducing or maintaining body weight in a mammal
WO2002098405A1
(en)
*
2001-06-05
2002-12-12
Ajinomoto Co., Inc.
Liver fibrosis inhibitors
PL1734970T3
(en)
2004-03-12
2015-05-29
Intercept Pharmaceuticals Inc
Treatment of fibrosis using fxr ligands
SI2953948T1
(en)
2013-02-07
2018-02-28
Scifluor Life Sciences, Inc
Fluorinated integrin antagonists
ES2892954T3
(en)
2015-02-19
2022-02-07
Ocuterra Therapeutics Inc
3-(2-oxo-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)imidazolidin-1-yl)propanoic acid fluorinated derivatives and uses thereof themselves
RU2017141561A
(en)
2015-04-30
2019-05-31
Сайфлуор Лайф Сайенсиз, Инк.
DERIVATIVES OF TETRAHYDRONAPHTHYRIDINYL-PROPONIC ACID AND THEIR APPLICATION
WO2017189828A1
(en)
2016-04-27
2017-11-02
Scifluor Life Sciences, Inc.
Nonanoic and decanoic acid derivatives and uses thereof
Family Cites Families (4)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
JPS6019891B2
(en)
*
1978-12-01
1985-05-18
第一製薬株式会社
Drug-induced fatty liver agent
JPS55102567A
(en)
*
1979-01-30
1980-08-05
Dai Ichi Seiyaku Co Ltd
Nicotinoylpantethine derivative
JPS5835118A
(en)
*
1981-08-28
1983-03-01
Dai Ichi Seiyaku Co Ltd
Remedy for hepatitis
GB2110536B
(en)
*
1981-12-04
1986-10-29
Sogo Pharm
Pharmaceutical compositions containing pantetheine-s-sulphonic acid
1988
1988-12-29
CA
CA000587236A
patent/CA1318254C/en
not_active
Expired – Fee Related
1989
1989-01-03
US
US07/292,793
patent/US4937266A/en
not_active
Expired – Fee Related
1989-01-04
AU
AU27723/89A
patent/AU614569B2/en
not_active
Ceased
1989-01-05
KR
KR1019890000030A
patent/KR970005324B1/en
not_active
IP Right Cessation
1989-01-05
PH
PH38005A
patent/PH26554A/en
unknown
1989-01-05
EP
EP89100180A
patent/EP0323855B1/en
not_active
Expired – Lifetime
1989-01-05
DE
DE68914468T
patent/DE68914468T2/en
not_active
Expired – Fee Related
1989-01-05
ES
ES89100180T
patent/ES2054881T3/en
not_active
Expired – Lifetime
Also Published As
Publication number
Publication date
AU614569B2
(en)
1991-09-05
EP0323855B1
(en)
1994-04-13
EP0323855A2
(en)
1989-07-12
CA1318254C
(en)
1993-05-25
DE68914468T2
(en)
1994-07-28
KR970005324B1
(en)
1997-04-15
DE68914468D1
(en)
1994-05-19
EP0323855A3
(en)
1990-12-05
ES2054881T3
(en)
1994-08-16
US4937266A
(en)
1990-06-26
KR890011588A
(en)
1989-08-21
PH26554A
(en)
1992-08-19
Similar Documents
Publication
Publication Date
Title
AU5018393A
(en)
1994-03-15
Preparation of solid state materials
AU3306789A
(en)
1989-11-02
Rotary sprinkler
AU6101190A
(en)
1991-02-21
Soilresisting agent
AU3015189A
(en)
1989-08-31
Cleansing compositions
AU637814B2
(en)
1993-06-10
Flavouring agent
AU8583391A
(en)
1991-12-19
New substituted azetidinones as anti-inflammatory and antidegenerative agents
AU3836889A
(en)
1989-12-12
Erosion protection structure
AU3029389A
(en)
1989-08-24
Tetrahydroisoquinoline derivatives
AU5359794A
(en)
1994-05-09
Quantification of indicators of fibrosis
AU2772389A
(en)
1989-07-13
Inhibitory agent of hepatic fibrosis
AU5175193A
(en)
1994-05-09
An accelerometer of the shear type
AU633307B2
(en)
1993-01-28
Dissolution of gas
AU5188093A
(en)
1994-06-09
Fungicidal derivatives of 2-alkoxy-2-imidazolin-5-ones
AU5184393A
(en)
1994-06-09
Substituted derivatives of diaminophthalimide
AU6723294A
(en)
1994-11-21
Use of simmondsine
AU4403289A
(en)
1990-05-01
Targetting agents
AU2784789A
(en)
1989-05-02
Antisyncytial agent
AU665073B2
(en)
1995-12-14
Novel thiosemicarbazone derivatives
AU4272685A
(en)
1985-11-28
Pyrazolin-5-one derivatives
AU4581089A
(en)
1990-06-14
N-substituted 2-cyano-3-oxo-3-substituted-proprionamides as anti-inflammatory agents
AU8484391A
(en)
1992-04-02
Cleaning of solutions of alkylphosphates
AU1957988A
(en)
1988-12-21
Hepatic blocking agents
AU2030288A
(en)
1989-02-09
Anti-hyperlipemic agent
AU5371694A
(en)
1994-05-24
Use of the tarchonanthus camphoratus
AU6357890A
(en)
1991-04-08
Expression of alpha-macroglobulins
None